Structural and biochemical studies of HIV and mmtv retroviral integration onto nucleosome-bound target DNA
Active Project Grant Awarded Last action
- Award ID
- F31AI189273
- Recipient
-
The Salk Institute For Biological Studies. San Diego. California UEI NNJ6BMBTFGN5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $237,932
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date 38% complete
- Place of performance
- La Jolla, CA 92037, USA
Award details come from USAspending.gov.
About this award
The National Institute of Allergy and Infectious Diseases awarded The Salk Institute for Biological Studies $237,932 on October 24, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct structural and biochemical studies of HIV and mouse mammary tumor virus (MMTV) retroviral integration onto nucleosome-bound target DNA.
The recipient will employ nucleosome reconstitution and sequencing strategies, biochemical binding and activity assays, and high-resolution cryogenic electron microscopy (cryo-EM) to mechanistically interrogate how and where retroviruses integrate viral DNA into chromatin. Three scientific aims will be developed using HIV and MMTV as model systems. Aim 1 will utilize a novel assay to interrogate intasome binding preferences on nucleosome assemblies. Aim 2 will define the preferred patterns of intasome-mediated integration into and around nucleosomes. Aim 3 will solve structures of intasomes bound to nucleosome assemblies using cryo-EM to dissect the mechanistic basis of integration into chromatin. Preliminary results revealed that intasomes selectively integrate into nucleosomal super helical locations not previously reported.
Work is performed in La Jolla, California. The period of performance runs from October 24, 2025, through June 30, 2028. This is a Project Grant, a standard assistance type under the program supporting investigator-initiated research addressing infectious and allergic disease.
Description
- Abstract
- Cells the integration of viral DNA (VDNA) into host chromatin establishes an infection in target and is a hallmark of the replication cycle of all retroviruses, including the human immunodeficiency virus (HIV). Integration is catalyzed by the intasome, a complex consisting of multimers of viral integrase proteins and short VDNA oligonucleotides. Most prior work used free target DNA to probe retroviral integration, largely due to experimental simplicity. However, eukaryotic host target DNA is chromatinized, with nucleosomes forming the core structural building blocks of the genome. Accordingly, our understanding of intasome-mediated integration into chromatin remains incomplete. This proposal will employ novel nucleosome reconstitution and sequencing strategies, biochemical binding and activity assays, and high-resolution cryogenic electron microscopy (CRYO-EM) to mechanistically interrogate how and where retroviruses integrate VDNA into chromatin. Three scientific aims will be developed using HIV and, as a simpler model system, the mouse mammary tumor virus (MMTV). In aim 1, a novel assay will be utilized to interrogate intasome binding preferences on nucleosome assemblies. In aim 2, the preferred patterns of intasome-mediated integration into and around nucleosomes will be defined. In aim 3, structures of intasomes bound to nucleosome assemblies will be solved using CRYO-EM to dissect the mechanistic basis of integration into chromatin. Preliminary results recently obtained revealed that intasomes selectively integrate into nucleosomal super helical locations that were not previously reported, highlighting both the novelty and significance of the proposed work. Collectively, these studies will advance mechanistic studies underlying the key integration step catalyzed by retroviruses, and the results will have important implications for understanding how these viruses cause diseases that affect millions of people around the world. During the training period, the PI will benefit from the collaborative and scientifically diverse environment present within the biological sciences PHD program at ucsd/salk institute. With the aid of his two sponsors, the PI will become proficient in numerous technical skills, including but not limited to protein expression and purifications, biochemical activity assays, next generation sequencing, and CRYO-EM data collection, processing, and atomic model refinement. Moreover, the PI will enhance his scientific soft skills by presenting his research at conferences, attending grant and manuscript writing workshops, mentoring undergraduate students, and teaching courses. Collectively, the nrsa predoctoral fellowship will prepare the PI to become an independent researcher for his next stage of academic training as a postdoctoral associate.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $49,724 | |
| Amendment | $0 | |
| Amendment | $564 | |
| Amendment | $46,911 | |
| Amendment | $0 | |
| Amendment | $46,911 | |
| Amendment | $0 | |
| Amendment | $46,911 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $46,911 |
Show all 12
Quick answers
Who received award F31AI189273?
F31AI189273 was awarded to The Salk Institute For Biological Studies. San Diego. California by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on October 24, 2025.
How much is award F31AI189273 worth?
$237,932 has been obligated on F31AI189273.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award